Eficácia e implementação clínica da dieta baixa em FODMAP na síndrome do intestino irritável: uma revisão sistemática

Autores

DOI:

https://doi.org/10.22516/25007440.1386

Palavras-chave:

Síndrome del intestino irritable, dieta FODMAP, signos y síntomas digestivos, calidad de vida, adherencia al tratamiento

Resumo

Introdução: Os distúrbios funcionais gastrointestinais, como a síndrome do intestino irritável, afetam significativamente a qualidade de vida. A dieta pobre em oligossacarídeos, dissacarídeos, monossacarídeos e polióis fermentáveis (FODMAP) surgiu como uma estratégia dietética eficaz. Esta revisão sistemática avalia as evidências sobre sua eficácia e aplicabilidade clínica em adultos com distúrbios funcionais gastrointestinais.
Metodologia: Foi realizada uma revisão sistemática conforme as diretrizes PRISMA 2020, registrada no PROSPERO (CRD1005339). Foram incluídos estudos publicados entre 2015 e 2025 que avaliaram a eficácia clínica da dieta FODMAP em comparação com uma dieta padrão ou grupo controle em adultos com distúrbios funcionais gastrointestinais. Foram considerados ensaios clínicos randomizados, estudos de coorte e revisões sistemáticas com metanálises. A seleção dos estudos, extração de dados e avaliação do risco de viés foram realizadas por dois revisores independentes utilizando a ferramenta Cochrane RoB 2.0.
Resultados: De 1750 registros identificados, 37 artigos em texto completo foram revisados e 22 estudos foram incluídos. Os resultados indicam redução significativa dos sintomas gastrointestinais, melhora na qualidade de vida e boa adesão à dieta.
Conclusões: A dieta FODMAP é eficaz no manejo dos sintomas em adultos com síndrome do intestino irritável. Sua implementação clínica deve ser individualizada e contar com acompanhamento profissional para otimizar a adesão e os resultados terapêuticos.

Downloads

Não há dados estatísticos.

Biografia do Autor

Olga Lucía Pinzón Espitia, Universidad Nacional de Colombia

Docente, Departamento de Nutrición Humana. Facultad de Medicina, Universidad Nacional de Colombia. Bogotá, Colombia.

Maria Catalina Barrera-Mojica, Universidad Nacional de Colombia

Nutricionista, Dietista egresada, Programa de Nutrición y Dietética, Departamento de Nutrición Humana, Facultad de Medicina, Universidad Nacional de Colombia. Bogotá, Colombia.

Paula Steffany Cruz Moya, Universidad Nacional de Colombia

Nutricionista, Dietista egresada, Programa de Nutrición y Dietética, Departamento de Nutrición Humana, Facultad de Medicina, Universidad Nacional de Colombia. Bogotá, Colombia.

Martín Alonso Gómez Zuleta, Universidad Nacional de Colombia

Docente, Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Unidad de Gastroenterología, Hospital Universitario Nacional de Colombia. Bogotá, Colombia.

Alejandro Concha-Mejía, Universidad Nacional de Colombia

Docente, Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Unidad de Gastroenterología, Hospital Universitario Nacional de Colombia. Bogotá, Colombia.

Referências

Palsson OS, Whitehead W, Törnblom H, Sperber AD, Simren M. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology. 2020;158(5):1262-1273.e3. https://doi.org/10.1053/j.gastro.2019.12.021

Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908-17. https://doi.org/10.1016/S2468-1253(20)30217-X

Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99-114.e3. https://doi.org/10.1053/j.gastro.2020.04.014

Ramírez Aranda JM, Martínez Gutiérrez CM, Fuentes Ramírez MM, Escobedo Ríos MR, Delgado Cuevas F del R. Familial aggregation in Irritable Colon Syndrome in Mexican patients. A case-control study. Aten Primaria. 2024;56(2):102794. https://doi.org/10.1016/j.aprim.2023.102794

Cañón M, Ruiz AJ, Rondón M, Alvarado J. Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian university: An electronic survey. Ann Gastroenterol. 2017;30(1):67-75. https://doi.org/10.20524/aog.2016.0093

Van den Houte K, Colomier E, Routhiaux K, Mariën Z, Schol J, Van den Bergh J, et al. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome. Gastroenterology. 2024;167(2):333-42. https://doi.org/10.1053/j.gastro.2024.02.008

Calcaterra V, Cena H, Loperfido F, Porri D, Basilico S, Gazzola C, et al. Functional Gastrointestinal Disorders and Childhood Obesity: The Role of Diet and Its Impact on Microbiota. Nutrients. 2025;17(1):123. https://doi.org/10.3390/nu17010123

Ribichini E, Scalese G, Mocci C, Severi C. Gut-Brain Axis and Psychopathology: Exploring the Impact of Diet with a Focus on the Low-FODMAP Approach. Nutrients. 2024;16(20):3515. https://doi.org/10.3390/nu16203515

Garicano Vilar E, Mendive P, Ríos MG, Rojo SS, Alessandra G, Torrontegui F, et al. This is not just any FODMAP diet: Hispanic adaptation of the FODMAP diet and a reintroduction guide. JONNPR. 2021;6(6):821-47. https://doi.org/10.19230/jonnpr.4274

Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. https://doi.org/10.31222/osf.io/v7gm2_v1

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https://doi.org/10.1186/s13643-016-0384-4

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366. https://doi.org/10.1136/bmj.l4898

Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, et al. Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial. Gastroenterology. 2015;149(6):1399-1407.e2. https://doi.org/10.1053/j.gastro.2015.07.054

Zahedi MJ, Behrouz V, Azimi M. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial. Journal of Gastroenterology and Hepatology (Australia). 2018;33(6):1192-9. https://doi.org/10.1111/jgh.14051

Guerreiro MM, Santos Z, Carolino E, Correa J, Cravo M, Augusto F, et al. Effectiveness of two dietary approaches on the quality of life and gastrointestinal symptoms of individuals with irritable bowel syndrome. J Clin Med. 2020;9(1):125. https://doi.org/10.3390/jcm9010125

Tunali V, Çidem Arslan N, Ermiş BH, Hakim GD, Gündoğdu A, Hora M, et al. A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2024;119(9):1901-12. https://doi.org/10.14309/ajg.0000000000002862

Rej A, Sanders DS, Shaw CC, Buckle R, Trott N, Agrawal A, et al. Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet. Clinical Gastroenterology and Hepatology. 2022;20(12):2876-2887.e15. https://doi.org/10.1016/j.cgh.2022.02.045

Patcharatrakul T, Juntrapirat A, Lakananurak N, Gonlachanvit S. Effect of structural individual low-fodmap dietary advice vs. Brief advice on a commonly recommended diet on ibs symptoms and intestinal gas production. Nutrients. 2019;11(12):2856. https://doi.org/10.3390/nu11122856

Varjú P, Farkas N, Hegyi P, Garami A, Szabó I, Illés A, et al. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies. PLoS One. 2017;12(8):e0182942. https://doi.org/10.1371/journal.pone.0182942

Wang J, Yang P, Zhang L, Hou X. A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis. Front Nutr. 2021;8:683191. https://doi.org/10.3389/fnut.2021.683191

Jent S, Bez NS, Haddad J, Catalano L, Egger KS, Raia M, et al. The efficacy and real-world effectiveness of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome: A systematic review and meta-analysis. Clinical Nutrition. 2024;43(6):1551-62. https://doi.org/10.1016/j.clnu.2024.05.014

Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. American Journal of Gastroenterology. 2016;111(12):1824-32. https://doi.org/10.1038/ajg.2016.434

Hahn J, Choi J, Chang MJ. Effect of Low FODMAPs Diet on Irritable Bowel Syndromes: A Systematic Review and Meta-Analysis of Clinical Trials. Nutrients. 2021;13(7):2460. https://doi.org/10.3390/nu13072460

Mohseni F, Agah S, Ebrahimi-Daryani N, Taher M, Nattagh-Eshtivani E, Karimi S, et al. The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial. Clin Nutr ESPEN. 2022;47:45-50. https://doi.org/10.1016/j.clnesp.2021.12.019

Harvie RM, Chisholm AW, Bisanz JE, Burton JP, Herbison P, Schultz K, et al. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World J Gastroenterol. 2017;23(25):4632-43. https://doi.org/10.3748/wjg.v23.i25.4632

Haghbin H, Hasan F, Gangwani MK, Zakirkhodjaev N, Lee-Smith W, Beran A, et al. Efficacy of Dietary Interventions for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. J Clin Med. 2024;13(24):7531. https://doi.org/10.3390/jcm13247531

Chojnacki C, Poplawski T, Blonska A, Konrad P, Chojnacki J, Blasiak J. The Usefulness of the Low-FODMAP Diet with Limited Tryptophan Intake in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome. Nutrients. 2023;15(8):1837. https://doi.org/10.3390/nu15081837

Roth B, Nseir M, Jeppsson H, D’Amato M, Sundquist K, Ohlsson B. A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS-A Randomized Non-Inferiority Study. Nutrients. 2024;16(17):3039. https://doi.org/10.3390/nu16173039

Eswaran S, Chey WD, Jackson K, Pillai S, Chey SW, Han-Markey T. A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable Bowel Syndrome and Diarrhea. Clinical Gastroenterology and Hepatology. 2017;15(12):1890-1899.e3. https://doi.org/10.1016/j.cgh.2017.06.044

van Lanen AS, de Bree A, Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr. 2021;60(6):3505-22. https://doi.org/10.1007/s00394-020-02473-0

Clevers E, Tran M, Van Oudenhove L, Störsrud S, Böhn L, Törnblom H, et al. Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome. Nutrition. 2020;73:110719. https://doi.org/10.1016/j.nut.2020.110719

So D, Loughman A, Staudacher HM. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis. Am J Clin Nutr. 2022;116(4):943-952. https://doi.org/10.1093/ajcn/nqac176

Staudacher HM, Ralph FSE, Irving PM, Whelan K, Lomer MCE. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet. J Acad Nutr Diet. 2020;120(4):535-47. https://doi.org/10.1016/j.jand.2019.01.017

Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. 2016;55(3):897-906. https://doi.org/10.1007/s00394-015-0922-1

Staudacher HM, Lomer MCE, Farquharson FM, Louis P, Fava F, Franciosi E, et al. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial. Gastroenterology. 2017;153(4):936-47. https://doi.org/10.1053/j.gastro.2017.06.010

NICE. Irritable bowel syndrome in adults: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2017.

World Gastroenterology Organization. Guía Práctica de la Organización Mundial de Gastroenterología Síndrome de Intestino Irritable: una Perspectiva Mundial. World Gastroenterology Organization; 2015.

Cangemi DJ, Lacy BE. Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions. Therap Adv Gastroenterol. 2019;12:1756284819878950. https://doi.org/10.1177/1756284819878950

Frieling T, Heise J, Krummen B, Hundorf C, Kalde S. Tolerability of FODMAP-reduced diet in irritable bowel syndrome-efficacy, adherence, and body weight course. Z Gastroenterol. 2019;57(6):740-4. https://doi.org/10.1055/a-0859-7531

Bellini M, Tonarelli S, Barracca F, Morganti R, Pancetti A, Bertani L, et al. A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up. Nutrients. 2020;12(8):2360. https://doi.org/10.3390/nu12082360

Goyal O, Batta S, Nohria S, Kishore H, Goyal P, Sehgal R, et al. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial. Journal of Gastroenterology and Hepatology (Australia). 2021;36(8):2107-15. https://doi.org/10.1111/jgh.15410

Algera JP, Demir D, Törnblom H, Nybacka S, Simrén M, Störsrud S. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial. Clinical Nutrition. 2022;41(12):2792-800. https://doi.org/10.1016/j.clnu.2022.11.001

Carter KA. Irritable bowel syndrome: Clinical practice update. J Am Acad Physician Assist. 2024;37(7):13-8. https://doi.org/10.1097/01.JAA.0000000000000035

Hillestad EMR, Steinsvik EK, Teige ES, Rasmussen SH, Brønstad I, Lundervold A, et al. Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2024;36(7):e14814. https://doi.org/10.1111/nmo.14814

Perez y Lopez N, Torrez-Lopez E, Zamarripa-Dorsey F. Respuesta clínica en pacientes mexicanos con síndrome de intestino irritable tratados con dieta baja en carbohidratos fermentables (FODMAP). Rev Gastroenterol Mex. 2015;80(3):180-5. https://doi.org/10.1016/j.rgmx.2015.06.008

Yepes I de J, Múnera MN, Martelo C. Dieta baja en oligosacáridos, disacáridos, monosacáridos y polioles fermentables y calidad de vida en pacientes con síndrome de intestino irritable en Colombia. Biomed. 2018;38(Sup.1):54-61. https://doi.org/10.7705/biomedica.v38i0.3443

Weynants A, Goossens L, Genetello M, De Looze D, Van Winckel M. The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome. Journal of Human Nutrition and Dietetics. 2020;33(2):159-69. https://doi.org/10.1111/jhn.12706

Di Rosa C, Van den Houte K, Altomare A, Guarino MPL, Besard L, Arts J, et al. DOMINO trial post hoc analysis: evaluation of the diet effects on symptoms in IBS subtypes. Therap Adv Gastroenterol. 2024;17:17562848241255296. https://doi.org/10.1177/17562848241255296

O’Keeffe M, Jansen C, Martin L, Williams M, Seamark L, Staudacher HM, et al. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterology and Motility. 2018;30(1). https://doi.org/10.1111/nmo.13154

Van Ouytsel P, Szalai A, Van Gossum A, Arvanitakis M, Louis H. Feasibility of a low FODMAPs diet without initial dietician intervention in the management of patients with irritable bowel syndrome: A prospective study. Acta Gastroenterol Belg. 2021;84(4):593-600. https://doi.org/10.51821/84.4.010

Wilson B, Cox SR, Whelan K. Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation. Proceedings of the Nutrition Society. 2021;80(1):19-28. https://doi.org/10.1017/S0029665120006990

Bruta K, Vanshika, Bhasin K, Bhawana. The role of serotonin and diet in the prevalence of irritable bowel syndrome: a systematic review. Translational Medicine Communications. 2021;6(1):1-9. https://doi.org/10.1186/s41231-020-00081-y

Giacosa A, Riva A, Petrangolini G, Allegrini P, Fazia T, Bernardinelli L, et al. Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis. Nutrients. 2022;14(3):416. https://doi.org/10.3390/nu14030416

Eswaran S, Jencks KJ, Singh P, Rifkin S, Han-Markey T, Chey WD. All FODMAPs Aren’t Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. 2025;23(2):351-358.e5. https://doi.org/10.1016/j.cgh.2024.03.047

Singh P, Chey SW, Nee J, Eswaran S, Dean G, Iturrino J, et al. Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 2025;23(2):362-364.e2. https://doi.org/10.1016/j.cgh.2024.04.021

Rej A, Aziz I, Tornblom H, Sanders DS, Simrén M. The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med. 2019;286(5):490-502. https://doi.org/10.1111/joim.12966

Valk R, Hammill J, Valk M. Efficacious, Nutritious and Delicious or Risky? Exploring the FODMAP Diet toManage and Treat Irritable Bowel Syndrome. New Emirates Medical Journal. 2024;5:e02506882269342. https://doi.org/10.2174/0102506882269342231212064600

Shaikh SD, Sun N, Canakis A, Park WY, Weber HC. Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review. J Clin Med. 2023;12(7):2558. https://doi.org/10.3390/jcm12072558

Lenhart A, Dong T, Joshi S, Jaffe N, Choo C, Liu C, et al. Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2021;20(3):e465. https://doi.org/10.1016/j.cgh.2021.05.027

Vervier K, Moss S, Kumar N, Adoum A, Barne M, Browne H, et al. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet. Gut. 2021;71(9):1821. https://doi.org/10.1136/gutjnl-2021-325177

Valdez-Palomares F, Nambo-Venegas R, Uribe-García J, Mendoza-Vargas A, Granados-Portillo O, Meraz-Cruz N, et al. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet. Food Funct. 2021;12(7):3206-18. https://doi.org/10.1039/D0FO03162C

Mehtab W, Agarwal A, Singh N, Malhotra A, Makharia GK. All that a physician should know about FODMAPs. Indian Journal of Gastroenterology. 2019;38(5):378-90. https://doi.org/10.1007/s12664-019-01002-0

Eswaran S, Dolan RD, Ball SC, Jackson K, Chey W. The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea. J Acad Nutr Diet. 2020;120(4):641-9. https://doi.org/10.1016/j.jand.2019.03.003

Lopes SS, Miszputen SJ, Sachs A, Lima MM, Ambrogini O. Evaluation of carbohydrate and fiber consumption in patients with irritable bowel syndrome in outpatient treatment. Arq Gastroenterol. 2019;56(1):03-9. https://doi.org/10.1590/s0004-2803.201900000-12

Amieva-Balmori M, Martínez-Pérez GP, Francisco MR, Triana-Romero A, Ortiz-Lorenzo AA, Hernández-Ramírez GA, et al. Dietary characteristics of Mexican patients with irritable bowel syndrome: Is there a distinction from the general population? Rev Gastroenterol Mex (Engl Ed). 2025;90(2):182-191. https://doi.org/10.1016/j.rgmxen.2025.05.004

Hernández-Velásquez DA, Rodríguez-Martínez E, Montoya-Meneses JD, González-Ceballos JS, Mosquera-Pérez K, Patiño-Mazuera L, et al. Clinical Characteristics and Treatment of Irritable Bowel Syndrome in a Colombian Population: A Cross-Sectional Study. Drugs Real World Outcomes. 2023;10(4):651. https://doi.org/10.1007/s40801-023-00395-x

Figura 1. Diagrama de flujo PRISMA para la selección de estudios. Imagen propiedad de los autores.

Publicado

2026-03-13

Como Citar

Pinzón Espitia, O. L., Barrera-Mojica, M. C., Cruz Moya, P. S., Gómez Zuleta, M. A., & Concha Mejía, A. (2026). Eficácia e implementação clínica da dieta baixa em FODMAP na síndrome do intestino irritável: uma revisão sistemática. Revista Colombiana De Gastroenterologia, 41(1), 62–77. https://doi.org/10.22516/25007440.1386

Edição

Seção

Revisión de tema

Métricas

Escanea para compartir
QR Code
Métricas do artigo
Vistas abstratas3031
Visualizações da cozinha838
Visualizações de PDF838
Visualizações em HTML0
Outras visualizações0

Alguns itens similares: